Effectiveness and Tolerability Profile of GLP-1 Receptor Agonists in Elderly Patients with Type 2 Diabetes

被引：0
|
作者：
Gorgojo-Martinez, Juan J.
Feo-Ortega, Gara
Serrano-Moreno, Clara
Sanz-Velasco, Alberto
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2264-PUB
引用
收藏
页码：A573 / A573
页数：1
相关论文
共 50 条
  • [1] Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
    Almohareb, Sumaya N.
    Alfayez, Osamah M.
    Aljuaid, Shoroq S.
    Alshahrani, Walaa A.
    Bakhsh, Ghalia
    Alshammari, Mohammed K.
    Al Yami, Majed S.
    Alshaya, Omar A.
    Alomran, Abdullah S.
    Korayem, Ghazwa B.
    Almohammed, Omar A.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [2] The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review
    Aroda, Vanita R.
    Ratner, Robert
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (06) : 528 - 542
  • [3] The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes
    Russell-Jones, D.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (10) : 1402 - 1414
  • [4] GLP-1 receptor agonists for type 2 diabetes
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    LANCET, 2009, 374 (9683): : 4 - 6
  • [5] Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes
    Trujillo, Jennifer
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 : 43 - 60
  • [6] GLP-1 receptor agonists in the management of Type 2 Diabetes
    Lambert, Lynn
    SA PHARMACEUTICAL JOURNAL, 2016, 83 (02) : 11 - 13
  • [7] GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus
    Dahiya, Lalita
    Kaur, Ramandeep
    Kumar, Rajiv
    Kumar, Manoj
    Palta, Kezia
    CURRENT DIABETES REVIEWS, 2020, 16 (04) : 279 - 292
  • [8] GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
    Isabel del Olmo-Garcia, Maria
    Francisco Merino-Torres, Juan
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [9] Efficacy and tolerability of GLP-1 agonists in patients with type 2 diabetes mellitus: an Indian perspective
    Dharmalingam, Mala
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2014, 5 (06) : 159 - 165
  • [10] Safety and tolerability of GLP-1 receptor agonists in patients with type 2 diabetes in comparator-controlled DURATION trials
    MacConell, L.
    Chen, S.
    Gurney, K.
    Malloy, J.
    Zhang, H.
    Zhou, M.
    Kolterman, O.
    DIABETOLOGIA, 2012, 55 : S329 - S329
12345